{
    "2021-12-08": [
        [
            {
                "time": "",
                "original_text": "【兴证策略 | 陆股通】配置盘与交易盘在哪些行业出现“分歧”？",
                "features": {
                    "keywords": [
                        "兴证策略",
                        "陆股通",
                        "配置盘",
                        "交易盘",
                        "行业分歧"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "多行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2022年度策略行业策略：核心五问揆情度理 先进制造+创新升级大处落墨",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2022年度策略",
                        "核心五问",
                        "先进制造",
                        "创新升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}